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ABSTRACT Connexin-assembled gap junctions
(GJs) and hemichannels coordinate intercellular sig-
naling processes. Although the regulation of connex-
ins in GJs has been well characterized, the molecular
determinants controlling connexin-hemichannel ac-
tivity are unresolved. Here we investigated the regu-
lation of Cx43-hemichannel activity by actomyosin
contractility and intracellular [Ca2!] ([Ca2!]i) using
plasma membrane-permeable TAT peptides (100
"M) designed to interfere with interactions between
the cytoplasmic loop (CL) and carboxy-terminal (CT)
in primary bovine corneal endothelial cells and
HeLa, C6 glioma, and Xenopus oocytes ectopically
expressing Cx43. Peptides corresponding to the last
10 CT aa (TAT-Cx43CT) prevented the inhibition of
Cx43-hemichannel activity by contractility/high
[Ca2!]i, whereas a reverse peptide (TAT-Cx43CTrev)
did not. These effects were independent of zonula
occludens-1, a cytoskeletal-associated Cx43-binding
protein. In contrast, peptides corresponding to CL
(TAT-L2) inhibited Cx43-hemichannel responses,
whereas a mutant peptide (TAT-L2H126K/I130N) did not
inhibit. In these assays, TAT-Cx43CT acted as a scaf-
fold for TAT-L2 and vice versa, a finding supported by
surface plasmon resonance measurements. Loop/tail
interactions appeared essential for Cx43-hemichannel
activity, because TAT-Cx43CT restored the activity of
nonfunctional hemichannels, consisting of either Cx43
lacking the C-terminal tail (Cx43M239) or intact Cx43
ectopically expressed in Xenopus oocytes. We conclude
that intramolecular loop/tail interactions control Cx43-
hemichannel activity, laying the basis for developing
hemichannel-specific blockers.—Ponsaerts, R., De
Vuyst, E., Retamal, M., D’hondt, C., Vermeire, D.,
Wang, N., De Smedt, H., Zimmermann, P., Himpens,
B., Vereecke, J., Leybaert, L., Bultynck, G. Intramolec-
ular loop/tail interactions are essential for connexin
43-hemichannel activity. FASEB J. 24, 4378–4395
(2010). www.fasebj.org
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Intercellular communication can occur via direct
and indirect signaling pathways. In vertebrates, the
protein family of connexins plays an important role in
both communication modes (1–4). Connexins can
regulate the spreading of intracellular messengers by
forming cell-to-cell coupling gap junctions (GJs) and
mediate paracrine communication by the release of
signaling molecules into the extracellular environment
via unopposed hemichannels (5). GJs are formed by
the juxtaposition at the intercellular interface of 2
hemichannels (connexons), which each consist of 6
connexin proteins. Connexins form highly conductive
and permeable channel complexes, allowing the flux of
hydrophilic signaling molecules smaller than 1.2 kDa,
including inositol 1,4,5-trisphosphate and ATP (2, 6).
Many of these signaling molecules provoke Ca2! signals
in neighboring cells, thereby controlling cellular func-
tion in multicellular systems (7). The activity of con-
nexin channels, particularly hemichannels, must be
tightly regulated and is characterized by brief openings
in normal, healthy cells (8). However, pathological
conditions may lead to more pronounced opening of
hemichannels (8–13), and under ischemic conditions
this may lead to a collapse of electrochemical gradients,
loss of metabolites, and massive Ca2! entry (14).
More than 20 connexin proteins have been identi-
fied in mammalian cells, characterized by distinct mo-
lecular weights. Some of these connexins appear to be
reserved for specific cell types, but connexin 43 (Cx43)
is widely expressed and ubiquitously present in a variety
of cell types, including the cells of major organs such as
heart and brain (15, 16). Recent studies provided
important insights in the modulation of GJ channel
gating. Delmar and co-workers (17–20) proposed that
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the closure of Cx43 GJ channels in response to acidifi-
cation is mediated by a “ball-and-chain” model whereby
the intracellular CT tail interacts with a receptor se-
quence on the CL (located between transmembrane
domains 2 and 3). This ball-and-chain model was also
invoked to explain chemical gating and the fast compo-
nent of voltage-dependent gating (18, 19). These findings
were supported by binding and structural approaches,
leading to the identification of an intramolecular interac-
tion between the CT tail and the L2 region (aa 119–144),
in the CL (21, 22). Physical binding of the ball (CT) to the
receptor (CL) induced a residual state with very low
conductance, whereas displacement of the ball from the
receptor provoked the full open state (23). Two residues
in the L2 region (H126 and I130) seemed to be important
for the structural integrity of this domain, which consists
of 2 "-helical structures (24). In addition, besides these
intramolecular interactions, the CT tail of Cx43 GJs also
interacts with a plethora of proteins, including cytoskel-
etal-associated proteins (reviewed in ref. 25–27).
Although much effort has been invested in under-
standing the functional regulation of GJs, our knowl-
edge on the regulation of hemichannels is still in its
infancy. The aim of the present work was to determine
whether intramolecular loop/tail interactions that are
known to regulate GJs also affect hemichannel activity.
MATERIALS AND METHODS
Cell culture
Primary cultures of bovine corneal endothelial cells (BCECs)
were established as described previously (28, 29). First- and
second-passage cells were used for experiments. HeLa cells
stably transfected with either the full-length Cx43 (30) or the
CT-truncated mutant of Cx43 (Cx43M239) (30) were main-
tained in DMEM, supplemented with 10% fetal bovine serum
(Invitrogen, Merelbeke, Belgium). C6 glioma cells stably
transfected with Cx43 (31) were maintained in DMEM:Ham’s
F12 (1:1; Invitrogen) supplemented with 10% fetal bovine
serum. For all live-cell microscopy experiments, BCECs were
seeded into 2-chambered glass slides at a density of 165,000
cells/chamber (4.2 cm2). For automated analysis using Flex-
Station 3 (Molecular Devices, Sunnyvale, CA, USA), BCECs
were plated out at 15,000 cells/well for 96-well plates. For
ATP-release measurements, HeLa and C6 cells were seeded at
a density of 105 cells/well in a 24-well plate and used on the
next day for experiments (subconfluent cultures).
Chemicals
Fluo-4 AM (F14217), Fura-2 AM (F1201), Dulbecco’s PBS
(14190-091), Dulbecco’s modified Eagle medium (11960-
044), l-glutamine (Glutamax, 35050-038), antibiotic-antimy-
cotic mixture (15240-096), Earle’s balanced salt solution
(14155-048), and trypsin (25300-054) were obtained from
Invitrogen. Fetal bovine serum (F-7524), a luciferin-luciferase
bioluminescence assay kit, ATP, apyrase VI (A6410), apyrase
VII (A6535), ARL-67156 (6-N,N-diethyl-#,$-dibromomethyl-
ene-d-ATP; A265), propidium iodide (PI; 81845), thrombin
(T-4648), LY (L-0259), and (%)-blebbistatin (B0560; a 1-phe-
nyl-1,2-pyrrolidine derivative) were obtained from Sigma-
Aldrich (Deisenhofen, Germany). The (!)-enantiomer of
blebbistatin was obtained from Calbiochem (203392; Merck
Biosciences, Darmstadt, Germany).
Peptides
All synthetic peptides (&90% pure) were obtained from
Thermo Electron (Ulm, Germany). Table 1 shows the sequence
of the different TAT-fused peptides used in this study. In all
experiments, TAT peptides were used at 100 'M and incubated
with the cells for 30 min at 37°C.
SiRNA against Cx43 in BCECs
SiRNA-duplex oligonucleotides against bovine Cx43
(gi 88319926:206-1357) were designed and screened for
off-target sequences using Batch RNAi selector (32) (sense
siCx43-1: 5(GAAGGAGGAGGAACU-CAAAdTdT; sense
siCx43-2: 5(CAAUUCUUCCUGCCGCAAUdTdT). A scram-
bled sequence of siCx43-1 was used as negative control
(sense siSCR: 5(GGUAAACG-GAACGAGAAGAdTdT). An-
nealed siRNA was purchased (Eurogentec, Luik, Belgium),
and BCECs were transfected in Gibco Optimem (Invitro-
gen) with HiPerFect transfection reagent (Qiagen, Venlo,
The Netherlands) following the manufacturer’s protocols.
After 4 h incubation, complete culture medium for BCECs
was added. Transfection efficiency of siRNA probes was
assessed by confocal microscopy using duplex siRNA, con-
taining a fluorescence Alexa Fluor 546 label at the 3( end
of the sense strand. Knockdown was examined by Western
blot analysis using mouse monoclonal anti-Cx43 (C8093;
Sigma-Aldrich). The purinergic P2X7-receptor was used as
a loading control using a rabbit polyclonal antibody
(P8232; Sigma-Aldrich). Immunoreactive bands were quan-
tified using ImageQuant (GE Healthcare BioScience, Upp-
sala, Sweden).
Scrape-loading dye transfer assay
Confluent BCECs were exposed to a PBS solution containing
Ca2! and Mg2! supplemented with 5 mg/ml PI, and a needle
TABLE 1. Overview of the sequence of different TAT-fused peptides used in this study
TAT peptide Peptide sequence
TAT-Cx43CT TAT-SRPRPDDLEI
TAT-Cx43CTrev TAT-SIELDDPRPR
TAT-Cx43CT)I TAT-SRPRPDDLE
TAT-L2 TAT-DGANVDMHLKQIEIKKFKYGIEEHGK
TAT-L2H126K/I130N TAT-DGANVDMKLKQNEIKKFKYGIEEHGK
TAT-Cx50CT TAT-SRARSDDLTV
TAT-Cx50L2 TAT-GGERAPLAADQGSVKKSSSSSKGTKK
YGRKKRRQRRR was used as the TAT sequence, which is responsible for cell penetration of the
peptides.
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scratch was applied. After 8 min, cells were washed with PBS
and fixed with 4% paraformaldehyde solution. DIC and
fluorescence images were acquired using confocal micros-
copy (LSM510; Carl Zeiss Meditec, Jena, Germany) with laser
excitation at 543 nm and emission detection with an LP585
filter.
Imaging of Ca2!-wave propagation
Ca2!-wave propagation was assayed as described previously.
In brief, BCECs were loaded with the Ca2!-sensitive fluores-
cent dye Fluo-4AM (10 'M) for 30 min at 37°C on a rocking
shaker. Fluo-4 loading and experiments were performed in
PBS (in mM: 0.9 CaCl2, 0.5 MgCl2, 2.7 KCl, 1.5 KH2PO4, 138
NaCl, 8.1 Na2HPO4, 25 glucose, pH 7.0). TAT peptides (100
'M) were present in the bath solution during Fluo-4 loading.
After washing the cells, Ca2! waves were elicited by briefly
touching the cell membrane with a glass micropipette cou-
pled to a piezoelectric crystal and visualized using confocal
microscopy with laser excitation at 488 nm and emission
detection at 530 nm. The total surface area of responsive cells
(active area) was determined using imaging software (LSM
Image 4.2; Zeiss). All values were obtained from at least 3
independent experiments, using 8–12 replicates/experi-
ment. Some experiments were performed in the presence of
apyrase VI (5 U/ml) ! apyrase VII (5 U/ml) or in the
presence of ARL-67156 (100 'M), indicated in the text as
apyrase and ARL, respectively.
Measurement of [Ca2!]i
BCECs were grown to confluence over 2–3 d in 96-well
plates (Cytowell 96F Fluocarbon Black, 146520; Nunc
Thermo Fisher Scientific, Rochester, NY, USA) and loaded
with 1.25 'M Fura-2 AM in PBS (in mM: 0.9 CaCl2, 0.5
MgCl2, 2.7 KCl, 1.5 KH2PO4, 138 NaCl, 8.1 Na2HPO4, 25
glucose, pH 7.0) for 30 min at room temperature (RT).
ATP-induced [Ca2!]i rises in BCECs were measured ratio-
metrically (excitation at 340 nm/380 nm, emission detec-
tion at 510 nm) in flex mode by optical bottom reading
(FlexStation 3). Rmax % R0 values of F340/F380 at different
[ATP] were fitted to a sigmoidal curve using Origin 7.0
(OriginLab Corp., Northampton, MA, USA).
Measurement of ATP release
BCECs, grown to confluence over 2–3 d in 96-well plates
(Microwell 96F White, 136101; Nunc), were incubated with
PBS (in mM: 0.9 CaCl2, 0.5 MgCl2, 2.7 KCl, 1.5 KH2PO4, 138
NaCl, 8.1 Na2HPO4, 25 glucose, pH 7.0) at 37°C for 30 min.
ATP release was measured by luciferin-luciferase biolumines-
cence in kinetic mode by top-reading (integration time 1000
ms) at pH 7.4 (HBSS buffer with 25 mM HEPES) in the
presence of EGTA (3.2 mM final). Next, cells were perme-
abilized with saponin (0.05% final), and the total ATP
amount was measured for each well. The photons emitted in
response to EGTA were normalized to the values obtained
after saponin treatment.
ATP release from HeLa and C6 cells was triggered by
applying A23187 (0.1, 2, and 10 'M) and determined with a
luciferin/luciferase assay kit as described previously (33, 34).
Cellular ATP release was accumulated over the period of
trigger exposure (5 min). Baseline measurements were per-
formed on separate cultures using standard HBSS-HEPES. All
values were calculated as fold induction compared to the
values obtained from baseline measurements. All individual
data points were obtained from at least 6 independent
measurements.
Measurement of Lucifer Yellow (LY) uptake
After treating BCECs with TAT peptides, cells were incubated in
Ca2!-free LY solution (PBS containing 2 mM EDTA and 2.5%
LY) for 5 min. Thrombin treatment preceded the exposure to
LY solution by 1 min. Excess of extracellular LY was washed away
with Ca2!-rich PBS. Dye uptake was visualized using confocal
microscopy (excitation at 488 nm, emission detection at 530
nm) (28, 35–37).
Visualization of TAT-Cx43CT peptides by
immunocytochemistry
After treating BCECs with TAT peptides, cells were fixed with
4% paraformaldehyde PBS solution for 20 min at 37°C and
subsequently permeabilized with a 0.05% saponin PBS solu-
tion. After blocking with 10% goat serum and 3% BSA,
samples were incubated with primary monoclonal anti-TAT
antibody (no. 2547, Cell Signaling Technology, Beverly, MA,
USA) for 3 h at RT in the presence of 1% glycine. After
washing, samples were incubated with the secondary antibody
(goat anti-mouse IgG-FITC, F-2012; Sigma-Aldrich) for 2 h at
RT. All incubation and washing steps were done in the
presence of 0.01% saponin. To check for nonspecificity of the
primary antibody, incubation with this antibody was omitted
in the negative control sample. Finally, cells were costained
for F-actin by incubation with Alexa-546 conjugated to
phalloidin (A22283; Invitrogen), as described previously
(37). Immunofluorescence images were acquired by con-
focal microscopy (LSM510) with a *63 oil-immersion
objective (1.4 NA).
Immunoprecipitation and Western blot analysis
Cells were lyzed in lysis buffer containing 1% Nonidet P-40,
40 mM Tris, 150 mMNaCl, 2 mM EDTA, 0.25% deoxycholate,
phosphatase inhibitors cocktail 1 ! 2 (P2850, P5726; Sigma-
Aldrich), and protease inhibitors (11873580001; Roche Ap-
plied Science, Mannheim, Germany). Cx43 was immunopre-
cipitated from the detergent-soluble lysate fraction with a
rabbit polyclonal antibody directed against the N-terminal
region of Cx43 (AP1541b; Abgent, San Diego, CA, USA),
using protein A/G plus agarose-beads (sc-2003; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Samples were sub-
jected to SDS-PAGE and Western blotting. Immunodetection
was performed as described previously (37): a mouse mono-
clonal IgM antibody directed against the CT of Cx43 (C8093;
Sigma-Aldrich) was used as primary antibody to detect immu-
noprecipitated Cx43. ZO-1 was detected using a mouse mono-
clonal IgG1 antibody (33-9100; Invitrogen). After incuba-
tion with the alkaline phosphatase-conjugated secondary
antibody and dephosphorylation of enhanced chemifluo-
rescence substrate (GE Healthcare), the immunoreactive
bands were visualized and quantified using a Storm840
FluorImager equipped with ImageQuant 5.2 software (Mo-
lecular Dynamics, Sunnyvale, CA, USA). Cx50 was detected
by using anti-N-terminal GJA8 antibody (AP1548a; Abgent)
and visualized using HRP-labeled secondary antibody and
ECL detection.
Purification of PDZ-2 domain of human ZO-1
The PDZ-2 domain of ZO-1 was cloned in a pGEX-5X vector
(GE Healthcare). The PDZ-2 domain was expressed in E. coli
and purified as described previously (38).
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Surface plasmon resonance (SPR) using biotin-Cx43CT
peptides
All SPR experiments were performed using Biacore 2000.
Equal amounts (resonance units) of &95% pure biotinylated
peptides were immobilized on each flow cell of a streptavidin-
coated sensor chip (BR-1000-32; Biacore, Uppsala, Sweden)
using HEPES buffer (in mM: 10 HEPES, 1 EDTA, 100 NaCl)
with 0.005% polysorbate-20 (Tween-20) at pH 7.4. Measure-
ments with analyte were done in HEPES buffer at a flow rate
of 30 'l/min. Binding of analyte was verified at different
concentrations, in random order (injection volume 120 'l).
Bound peptide was removed by injection of 10 'l regenera-
tion buffer (50 mM NaOH, 1 M NaCl) at 10 'l/min.
Measurements with TAT-L2 were done in analytically pre-
pared buffers containing 500 nM free [Ca2!], calculated via
CaBuf (G. Droogmans; ftp://ftp.cc.kuleuven.ac.be/pub/
droogmans/cabuf.zip). Background signals obtained from
the reference flow cell, containing the reversed biotinylated
peptide, were subtracted to generate response curves. In each
sensorgram, the first and the second arrows illustrate the
beginning of association and dissociation, respectively.
cRNA preparation and injection into Xenopus laevis oocytes
Cx43 cDNA was obtained from Dr. Guillermo Altenberg
(Texas Tech University Health Sciences Center, College
Station, TX, USA) as plasmid pOocyte-Cx43. The cDNA was
first linearized with SalI, and then cRNA was obtained by
using T7-directed capped cRNA synthesis kit (mMessage
Machine; Ambion, Austin, TX, USA). The cRNA was precip-
itated overnight with LiCl at%80°C. Oocytes were obtained as
described previously (39). Briefly, extracted oocytes were
incubated in OR2 (in mM: 82.5 NaCl, 2 KCl, 1 MgCl2, and 5
HEPES, pH 7.4) solution plus 0.5 mg/ml of collagenase for
80 min at RT under constant rotation. Then, oocytes were
washed 3 times (15 min each) with OR2 solution and then
twice (15 min each) with Barth(s solution (in mM: 88 NaCl, 1
KCl, 1.8 CaCl2, 1.0 MgCl2, 10 HEPES, pH 7.4, supplemented
with 0.1 mg/ml gentamicin and 20 U/ml of penicillin and
streptomycin). Finally, oocytes were kept in Barth’s solution,
and the medium was changed each 1–2 d. Oocytes were
injected with antisense Cx38 (12.5 ng) oligonucleotide and
cRNA coding for Cx43 (50 ng). All experiments were per-
formed after 48 h post-cRNA injection.
Electrophysiological recordings and analysis
Hemichannel currents were measured as described previously
(39). Briefly, oocytes were bathed at RT with ND96 solution
(in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1.0 MgCl2, and 5 HEPES,
pH 7.4). Two-electrode whole-cell voltage-clamp recordings
and analysis were performed with pClamp 10/Digidata 1440A
A/D Board (Molecular Devices, Foster City, CA, USA).
Hemichannel currents were measured as 15-s square pulses,
ranging from %60 to ! 60 mV in 10-mV steps, with a
following 10-s interval between pulses at holding potential
equal to %60 mV. Current-voltage (I–V) relationships were
calculated from the current values at the end of each depo-
larizing pulse.
Statistical analysis
Results are expressed as means + se, and n refers to the
number of independent experiments. For statistical analyses,
each treatment was compared to its respective control, and
significance was determined using a 1-way ANOVA or paired
Student’s t test, as appropriate. Differences were considered
significant at P , 0.05.
RESULTS
Intercellular Ca2!-wave propagation in BCECs is
mainly driven by Cx43 hemichannel-mediated ATP
release
We examined intercellular communication in BCECs
by measuring intercellular Ca2!-wave propagation
and ATP release. Ca2!-wave propagation was trig-
gered by applying a mechanical stimulus (MS) to a
single cell of the monolayer, and the total surface
area of the responding cells (active area) was quan-
tified. We previously demonstrated that intercellular
communication in monolayers of BCECs relies in
large part on a paracrine pathway that involves ATP
release via hemichannels (28, 29). Figure 1A shows
the active area determined in untreated BCECs and
cells treated either with ARL, an inhibitor of ecto-
ATPases (40), or with apyrases, enzymes catalyzing
the hydrolysis of ATP. The ARL treatment increases
ATP-dependent intercellular communication by inhib-
iting ATP hydrolysis, whereas the apyrase treatment
inhibits ATP-mediated intercellular communication,
rendering cells largely dependent on GJ coupling for
their intercellular communication. Figure 1A shows
that ARL treatment increased the active area -3.4-fold,
whereas apyrase treatment reduced the active area to
-30% of the original value. These results indicate that
mechanical stimulation-induced Ca2!-wave propaga-
tion largely depends on hemichannel-mediated ATP
release.
To clarify the cellular role of Cx43 hemichannels in
our cell system, we investigated intercellular communi-
cation after Cx43 knockdown. Using a fluorescently
labeled probe, we show that the majority of cells in
confluent BCEC monolayers contained the siRNA
probes (Supplemental Fig. 1). Both siCx43 probes
provoked a knockdown of Cx43 at the protein level of
-90% relative to P2X7 levels, which were used as a
loading control (Fig. 1B). Furthermore, both siCx43
probes provoked a pronounced decrease in the spread-
ing of PI in scrape-loaded BCECs (Fig. 1C), indicating
that BCECs contain functional Cx43 GJs.
Next, we investigated the effect of siCx43 on inter-
cellular communication by measuring intercellular
Ca2!-wave propagation (Fig. 1D, E, G) and ATP release
(Fig. 1H). Both siCx43 probes potently decreased the
active area compared to control conditions (Fig. 1E and
Supplemental Fig. 2A), whereas the amplitude of the
[Ca2!]i rise in the MS cell was not significantly affected
(Table 2). Furthermore, siRNA treatment did not sig-
nificantly affect the ATP-induced [Ca2!]i increase (Fig.
1F). The active area was also determined in the pres-
ence of ARL and apyrases (Fig. 1G). Treatment of the
cells with siCx43 probes resulted in a very marked,
significant reduction in the active area in the presence
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of ARL, but had no significant effect in the presence of
apyrases, demonstrating that Ca2!-wave propagation in
BCECs largely depends on ATP release via Cx43
hemichannels.
Next, we assessed the effect of Cx43 knockdown on
hemichannel-mediated ATP release triggered by expos-
ing BCECs to a Ca2!-free solution containing EGTA, a
potent trigger for connexin-hemichannel opening (41–
44). Cells treated with siCx43-1 or siCx43-2 displayed a
55% decrease in the amount of EGTA-induced ATP
release (Fig. 1H).
Taken together, these results indicate that Ca2!-wave
propagation in BCECs is in large part mediated by
signaling via Cx43 hemichannels, despite the presence
of functional Cx43 GJs. Therefore, Cx43 is a major
player in ATP-mediated paracrine communication in
BCECs.
A peptide corresponding to the last 10 CT aa of
Cx43 (TAT-Cx43CT) prevents thrombin-induced
inhibition of intercellular Ca2! waves and LY uptake
Because Cx43 plays an important role in ATP-depen-
dent paracrine signaling in BCECs (Fig. 1) and because
Figure 1. Endogenous Cx43 mediates
intercellular communication and
hemichannel-mediated ATP release in
BCECs. A) Active area of the intercel-
lular Ca2!-wave propagation in BCECs
in control conditions, in the presence
of ARL and in the presence of apyrase.
B) Immunoblot of Cx43 and P2X7 in
lysates prepared from BCECs treated
with different amounts (20, 50, and
100 nM) of siRNA duplexes (2 inde-
pendent siRNA probes against Cx43: siCx43-1 and siCx43-2; a scrambled siRNA probe: siSCR). Controls are always treated
with transfection reagent only. Numbers in bottom row indicate Cx43-protein levels relative to the P2X7-protein levels. C) Scrape
loading of BCECs with propidium iodide (red) in the presence of different siRNA probes. D, E) MS-induced intercellular Ca2!-wave
propagation in BCECs treated with siRNA duplexes.D) Representative images beforeMS (left), at the time ofMS (middle), and at the
time when the Ca2!-wave propagation reaches its maximal spreading (active area; right). E) Quantitative analysis of the active area of
the intercellular Ca2!-wave propagation (n.4). F) Normalized ATP-induced [Ca2!]i rise in BCECs treated with siRNA duplexes.
G)Quantitative analysis of the active area of the intercellular Ca2!-wave propagation in the presence of eitherARLor apyrase inBCECs
treated with siRNA duplexes. H) Ca2!-free solution-induced ATP release from BCECs treated with siRNA duplexes (n.4).
TABLE 2. Relative Fluo-4 fluorescence increase ()F/F0) in the
MS cell
Treatment Relative fluorescence units
Control 0.815 + 0.126
siCx43-1 0.742 + 0.250
siCx43-2 0.673 + 0.188
siSCR 0.872 + 0.152
Values are expressed as means + se from 3 independent
experiments. Control was treated with transfection reagent. Values
do not differ significantly from control (P&0.1; paired t test).
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thrombin inhibits this paracrine component (35) by
increasing actomyosin contractility (37), we investi-
gated the mechanism by which the contractile system
regulates Cx43-hemichannel activity (see Fig. 10 for the
model).
For Cx43 GJ channels, the 220-kDa peripheral mem-
brane protein ZO-1 has been shown to link the acto-
myosin cytoskeleton with the CT tail of Cx43 and
regulate Cx43-channel activity (45–47). The 4 aa lo-
cated at the CT end (DLEI) of Cx43 act as PDZ-binding
domain responsible for the interaction with the second
PDZ domain of ZO-1 (48–50). Note that antennapedia-
coupled peptide corresponding to the last 9 aa of Cx43
was able to inhibit the endogenous interaction between
PDZ-2 of ZO-1 and Cx43 GJs (46).
In this study we investigated whether the CT part of
Cx43 is also involved in the inhibitory effect of throm-
bin on intercellular communication. Therefore, we
developed cell-permeable peptides corresponding to
the last 10 aa of Cx43 (TAT-Cx43CT) and its reverse
sequence (TAT-Cx43CTrev). Covalent coupling of pep-
tides to the TAT sequence is a well-documented ap-
proach for cellular delivery of peptides (51).
First, we show that both peptides accumulated in the
intracellular environment of BCECs (Fig. 2A). Second,
we examined the effect of these peptides on the
thrombin-induced inhibition of Ca2!-wave propagation
and LY uptake. The Ca2!-wave propagation experi-
ments were performed in the absence and presence of
ARL. As previously shown, thrombin caused a marked
reduction in the active area in BCECs (Fig. 2B, top
panel) (35, 37). Interestingly, preincubation with TAT-
Cx43CT largely prevented the inhibition of the Ca2!-
wave propagation by thrombin in the absence as well as
in the presence of ARL, whereas TAT-Cx43CTrev did
not have any effect. Furthermore, these peptides did
not affect the Ca2!-wave propagation in the absence of
thrombin. TAT-Cx43CT also prevented the inhibitory
effect of thrombin on LY uptake in response to Ca2!-
free solution (Fig. 2C).
Third, we examined the contribution of Cx50 in our
cell system for the following reasons: Cx43 and Cx50
are both GJA-type connexins; the CT region of Cx43
and Cx50 display homology; and we have found Cx50 at
the mRNA level in BCECs (52). However, the effects of
TAT-Cx43CT are unlikely to be due to effects on Cx50:
Cx50 protein could not be detected by Western blot
analysis using an anti-Cx50 antibody in BCECs (Supple-
mental Fig. 3A), and TAT-Cx50CT (last 10 aa of Cx50)
did not affect the thrombin-induced inhibition of the
Ca2!-wave propagation (Supplemental Fig. 3B). Be-
cause TAT-Cx50CT resembles TAT-Cx43CT except for
2 proline residues, the latter result also suggests that
Figure 2. TAT-Cx43CT peptides prevent
thrombin-induced inhibition of hemichan-
nel opening in BCECs. Cells were pre-
treated with 100 'M of TAT-Cx43CT or
TAT-Cx43CTrev before adding either PBS
or thrombin. A) Immunofluorescence of
TAT peptides in BCECs using monoclonal
anti-TAT (green). F-actin is stained with
phalloidin-AlexaFluor546 (red). B) Throm-
bin-induced inhibition of intercellular
Ca2!-wave propagation in BCECs in re-
sponse to MS pretreated with different TAT
peptides in the absence (top panel) and
presence (bottom panel) of ARL. Quantifi-
cation of the normalized active area is
shown (n.4). *P , 0.05 vs. control or
TAT-Cx43CTrev-treated cells, both preincubated with thrombin. C) Thrombin-induced inhibition of LY uptake induced by
Ca2!-free solution in BCECs pretreated with TAT-Cx43CT. Scale bars . 20 'm.
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the proline residues are important for the effects of
TAT-Cx43CT.
Thrombin-induced inhibition of intercellular Ca2!
waves is not mediated through ZO-1
Because TAT-Cx43CT prevents thrombin-induced inhi-
bition of Cx43-hemichannel activity, we investigated
whether this effect of TAT-Cx43CT was due to disturb-
ing the interaction of ZO-1 with the CT tail of Cx43.
Therefore, we developed a TAT-Cx43CT)I peptide,
lacking the last isoleucine residue that is essential for
binding of Cx43 with the PDZ-2 domain of ZO-1
(PDZ2ZO-1) (48, 53).
First, we confirmed whether the last isoleucine of the
Cx43CT peptide is essential for interaction with PDZ2ZO-1.
Therefore, the binding of purified PDZ2ZO-1 to immobilized
biotin-Cx43CT was examined using SPR (Fig. 3A). As shown
previously (54), addition of PDZ2ZO-1 caused concentration-
dependent changes in the angle of resonance, indicating a
specific interaction between biotin-Cx43CT and PDZ2ZO-1.
ExcessCx43CT largely prevented thebindingof PDZ2ZO-1 to
the immobilized biotin-Cx43CT, whereas Cx43CT)I did
not. These results confirm that the last isoleucine residue of
Cx43 was essential for the interaction of Cx43 with the
PDZ2ZO-1, enabling us to investigate the possible involve-
ment of ZO-1 in thrombin-induced inhibition of hemichan-
nels in BCECs.
Second, we investigated the effects of TAT-Cx43CT)I on
the thrombin-induced inhibition of MS-induced Ca2!-wave
propagation. Strikingly, TAT-Cx43CT)I (like TAT-Cx43CT)
completely prevented the inhibition of intercellular Ca2!-
wave propagation by thrombin (Fig. 3B), indicating that
ZO-1 was not involved in this process.
Third, ZO-1 did not specifically coimmunoprecipi-
tate with Cx43 solubilized from BCEC lysates that were
either untreated or treated with thrombin (Fig. 3C).
Taken together, these data provide evidence that ZO-1
is not involved in the effects of TAT-Cx43CT on throm-
bin-induced inhibition of Cx43 hemichannel-mediated
intercellular communication.
TAT-L2 inhibits Cx43-hemichannel responses
Besides the PDZ-2-binding motif, TAT-Cx43CT con-
tains a stretch of aa previously shown to interact with
the CL of Cx43 (17, 22–24, 55), but it is not known
whether the residues present in TAT-Cx43CT are
sufficient for binding CL. We investigated whether
such loop/tail interaction exists in Cx43 hemichan-
nels and whether TAT-Cx43CT could interfere with
it. Therefore, we developed a cell-permeable peptide
(TAT-L2) that corresponds to the L2 region. We also
developed a modified TAT-L2, in which 2 aa essential
for binding of L2 to the CT tail of Cx43 were mutated
(TAT-L2H126K/I130N) (23).
Strikingly, TAT-L2, but not TAT-L2H126K/I130N,
provoked a potent decrease in the active area of
Ca2!-wave propagation on MS (Fig. 4A). These ob-
servations were confirmed in the presence of ARL
(Fig. 4B). Both results point to a strong inhibition of
hemichannel responses by TAT-L2. Furthermore, the
inhibition of the active area by TAT-L2 was com-
pletely abolished when ATP-mediated paracrine in-
tercellular communication was inhibited by apyrases,
and intercellular communication solely relied on GJs
(Fig. 4C). The latter experiment excludes the possi-
bility that the inhibitory effects of TAT-L2 on Ca2!-
wave propagation were due to inhibition of Cx43 GJ
channels. Therefore, these data indicate that the
effect of TAT-L2 on intercellular communication is
mainly due to inhibition of hemichannel-mediated
ATP release, thereby resembling the effects of throm-
bin. Because TAT-Cx50L2 (corresponding L2 region
from Cx50) did not affect the active area of the
Figure 3. TAT-Cx43CT-mediated suppression of thrombin-induced inhibition of hemichannel opening in BCECs does not
involve ZO-1. A) Sensorgrams illustrating the binding of the PDZ-2 domain of ZO-1 (3.3 'M) to biotin-Cx43CT immobilized to
a streptavidin-coated sensor chip. Untagged Cx43CT (red) or Cx43CT)I (green) peptides were preincubated in excess (33 'M)
with PDZ-2 (3.3 'M) to compete for binding of PDZ-2 to the immobilized biotin-Cx43CT. A representative experiment is shown
(n.3). B) Thrombin-induced inhibition of intercellular Ca2!-wave propagation in BCECs pretreated with TAT-Cx43CT)I in
response to MS. Quantification of the normalized active area is shown (n.3). C) Immunoblots of ZO-1 and Cx43 of samples
obtained after immunoprecipitation of Cx43 from lysates prepared from PBS- and thrombin-treated BCECs. The double lines
indicate that the lanes were taken from another part of the same gel. The lowest band in the lysate of the Cx43 blot is GAPDH,
which was stained to monitor the washing conditions of immunoprecipitated complexes.
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Ca2!-wave propagation on MS, Cx50 seemed not to
be involved (Supplemental Fig. 3C).
To elaborate on the inhibitory effect of TAT-L2 on the
Cx43-hemichannel opening, we investigated ATP release
from Cx43-expressing HeLa cells in response to other
triggers. On the one hand, we applied 2 'M of the Ca2!
ionophore A23187, elevating [Ca2!]i to the 500 nM range
(Fig. 5A) and provoking Cx43 hemichannel-mediated
ATP release in this cell system (Fig. 5B, C) (34, 56). On
the other hand, we applied a Ca2!-free solution to open
hemichannels (Fig. 5D). Strikingly, in both trigger condi-
tions, TAT-L2 potently inhibited ATP release from these
cells. In contrast, the mutant version of TAT-L2 (TAT-
L2H126K/I130N) was much less efficient than TAT-L2 in
inhibiting Cx43-hemichannel responses (Fig. 5B), indicat-
ing that the inhibition of Cx43-hemichannel responses by
TAT-L2 involves the CT tail-binding properties of the L2
region.
Because L2 can bind to the CT tail of Cx43, we
investigated whether the inhibitory effects of TAT-L2
were influenced by the presence of TAT-Cx43CT (Fig.
5C, D). Therefore, we coincubated TAT-L2 with either
TAT-Cx43CT or TAT-Cx43CTrev. These experiments
revealed that TAT-Cx43CT, but not TAT-Cx43CTrev,
was able to overcome the inhibition of Cx43 hemichan-
nel-mediated ATP release by TAT-L2.
These data indicate that TAT-L2 inhibits Cx43
hemichannels by acting on the last 10 aa of Cx43,
thereby interfering with intramolecular loop/tail in-
teractions. Furthermore, TAT-Cx43CT neutralizes
the inhibitory action of TAT-L2 on Cx43 hemichan-
nels.
Figure 4. TAT-L2 peptide inhibits hemichannel opening in BCECs. A) BCECs were treated with either TAT-L2 or
TATL2H126K/I130N, and the active area of the MS-induced Ca2!-wave propagation was quantified (n.3). B) Similar experiment
as in panel A, but in the presence of ARL. C) Similar experiment as in panel B, but in the presence of apyrase. *P , 0.05 vs.
untreated cells or TAT-L2H126K/I130N-treated cells.
Figure 5. TAT-L2 peptide in-
hibits hemichannel opening in
HeLa cells ectopically express-
ing Cx43. A) Dose-response
curve showing the amplitude
of [Ca2!]i transients as a function
of different [A23187], obtained
from at least 3 independent exper-
iments. The inset shows [Ca2!]i
transients monitored in response
to 0.1, 2, and 10 'M A23187. B)
ATP release from Cx43-expressing
HeLa cells in response to 2 'M
A23187. Cells were treated for 30
min with either TAT-L2 or TAT-
L2H126K/I130N. C, D) Cx43-ex-
pressing HeLa cells were treated
with either TAT-Cx43CT, TAT-
L2, TAT-Cx43CT ! TAT-L2, or
TAT-Cx43CTrev! TAT-L2. Data
show ATP release as fold induc-
tion of baseline values (n.10)
from Cx43-expressing HeLa
cells in response to 2 'M
A23187 (C) or Ca2!-free solu-
tion containing the Ca2!
buffer EGTA (D).
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Cx43CT interacts with the L2 region of Cx43
Because inhibition of Cx43-hemichannel activity by
TAT-L2 is alleviated by TAT-Cx43CT and because we
propose that these peptides affect the loop/tail gat-
ing of Cx43 hemichannels, we investigated in an
independent way whether Cx43CT interacts with the
L2 region. Using SPR, we examined the binding of
L2 to immobilized biotin-Cx43CT. Biotin-Cx43CTrev
was used as a control. Figure 6A illustrates sensor-
grams of different concentrations of the TAT-L2
peptide. The SPR measurements demonstrated a
clear concentration-dependent change in resonance
units on addition of TAT-L2, indicating a specific
interaction between biotin-Cx43CT and TAT-L2.
Furthermore, the binding of TAT-L2 to biotin-
Cx43CT was promoted by decreasing the pH from 6.8
to 5.8 (Fig. 6B). Decreasing the pH favors the "-helical
structure of the L2 sequence and enhances binding of
the tail to the loop (22), suggesting that the structural
properties of the L2 region are important for its
binding to Cx43CT.
These data indicate that the last 10 aa of Cx43 are
sufficient to interact with the L2 region of Cx43.
Addition of cell-permeable peptides corresponding to
these regions may therefore disturb endogenous loop/
tail interactions of Cx43 hemichannels and affect the
regulation of Cx43.
(#)-Blebbistatin and TAT-Cx43CT overcome the
inhibition of Cx43-hemichannel responses induced by
high [Ca2!]i
To further elucidate the mechanism by which the CT
tail is involved in regulating Cx43-hemichannel activ-
ity, we studied ATP release in HeLa and C6 glioma
cells ectopically expressing Cx43. Recently De Vuyst
et al. (56) demonstrated that Cx43 expressed in C6 or
HeLa cells displayed a bell-shaped dependence to-
ward [Ca2!]i. By applying different [A23187], it was
shown that [Ca2!]i changes with a peak in the 500
nM range (“medium [Ca2!]i” provoked by 2 'M
A23187; Fig. 5A) induced Cx43 hemichannel-
mediated ATP release, whereas ATP release was abol-
ished when [Ca2!]i was elevated to values in the order
of 1–2 'M (“high [Ca2!]i” provoked by 10 'M A23187;
Fig. 5A), pointing to an inhibitory effect of high [Ca2!]i
(56). We wondered whether this inhibition of
hemichannel responses by high [Ca2!]i resembled the
inhibition of hemichannel responses in BCECs by
thrombin and could be overcome by 5 'M (%)-
blebbistatin (a specific inhibitor of myosin II ATPase
activity; 57) or by TAT-Cx43CT peptides (Fig. 7A). We
anticipated that high [Ca2!]i would trigger actomyosin
contractility and in this way inhibit Cx43-hemichannel
opening, similar to the effect of thrombin in BCECs,
which sensitizes the cells toward Ca2!-induced contrac-
tility.
First, pretreatment of Cx43-expressing HeLa cells
with (%)-blebbistatin prevented the inhibition of Cx43
hemichannel-mediated ATP release by high [Ca2!]i
(triggered by 10 'M A23187), whereas the inactive
enantiomer (!)-blebbistatin had no influence (Fig.
7B). Notably, (%)-blebbistatin did not significantly af-
fect the activation of Cx43 hemichannels by medium
[Ca2!]i (triggered by 2 'MA23187). These effects were
confirmed in Cx43-expressing C6 glioma cells (Supple-
mental Fig. 4A).
Second, pretreatment of Cx43-expressing HeLa cells
with TAT-Cx43CT prevented the inhibition of Cx43-
hemichannel-mediated ATP release by high [Ca2!]i,
whereas the TAT-Cx43CTrev control peptide did not
(Fig. 7C). Furthermore, these effects appeared to be
independent of the interaction of Cx43 with ZO-1,
Figure 6. TAT-L2 peptide binds to biotin-Cx43CT immobilized to streptavidin-coated sensor chip. Sensorgrams illustrating the
binding of TAT-L2 to biotin-Cx43CT immobilized to a streptavidin-coated sensor chip. Values were corrected for background
binding of TAT-L2 to biotin-Cx43CTrev. First and second arrows illustrate the beginning of association and dissociation,
respectively. A) Signals increase with increasing TAT-L2 concentrations, indicating a specific binding of TAT-L2 to biotin-
Cx43CT. B) Signals increase by lowering the pH from 6.8 to 5.8, which favors the "-helical structure of the TAT-L2 peptide.
Representative experiments from 3 independent experiments are shown.
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since TAT-Cx43CT)I also prevented this inhibition.
These results were confirmed in Cx43-expressing C6
glioma cells (Supplemental Fig. 4B). Again, there was
no effect of the TAT-Cx43CT peptides on the ATP
release provoked by 2 'M A23187 (medium [Ca2!]i).
Third, as already shown in Fig. 4C, TAT-L2 and
TAT-Cx43CT were able to neutralize and counteract
each other (Fig. 7D). As a result, TAT-Cx43CT neutral-
ized the inhibitory effect of TAT-L2 on a Cx43-
hemichannel opening by medium [Ca2!]i (Fig. 7D;
compare Œ with ! at 2 'M A23187), whereas the
TAT-L2 neutralized the ability of TAT-Cx43CT to over-
come the inhibition of Cx43-hemichannel opening by
high [Ca2!]i (Fig. 7D; compare F with ! at 10 'M
A23187). As a result, in the presence of TAT-L2,
TAT-Cx43CT was not able to overcome the inhibition
of Cx43 hemichannel-mediated ATP release, and there-
fore Cx43 hemichannel-mediated ATP release was in-
hibited by high [Ca2!]i.
In addition, we measured in Cx43-expressing HeLa
cells the dose response for TAT-Cx43CT on ATP release
triggered by 10 'M A23187 (Fig. 7E) and for TAT-L2 on
ATP release triggered by 2 'M A23187 (Fig. 7F). These
results indicate that TAT-Cx43CT overcomes the inhibi-
tion of Cx43 hemichannels in response to high [Ca2!]i
with an EC50 of-10 'M with a maximal effect at 100 'M
and that TAT-L2 inhibits medium [Ca2!]i-induced Cx43
hemichannel activity with an IC50 of -11 'M with a
maximal effect at 100'M. These results indicate that both
peptides are taken up with similar efficiencies and inter-
fere with loop/tail interaction with similar affinities. As an
additional control, we used TAT-Cx50L2 (100 'M). This
peptide did not inhibit the Cx43 hemichannel-mediated
ATP release triggered by 2 'M A23187 (Supplemental
Fig. 3D).
Taken together, these results indicate that contractil-
ity and the last 10 CT aa of Cx43 are involved in the
inhibition of Cx43-hemichannel responses by high
[Ca2!]i and that these effects are mediated through the
L2 region of Cx43 hemichannels.
Effect of (#)-blebbistatin on inhibition of Cx43
hemichannels by high [Ca2!]i requires the CT tail of
Cx43
Since inhibition of Cx43 hemichannel responses by
high [Ca2!]i was counteracted by (%)-blebbistatin as
well as by TAT-Cx43CT, we investigated whether the
presence of the CT tail of Cx43 was required for the
effect of (%)-blebbistatin. Therefore, we used HeLa
cells expressing Cx43M239, a truncated version of Cx43
that lacks the complete CT. As shown in previous
studies, the CT is essential for Cx43-hemichannel
activity (33, 58). Here we confirm that in contrast to
full-length Cx43, a rise in [Ca2!]i was not able to
provoke ATP release from Cx43M239-expressing HeLa
Figure 7. (%)-Blebbistatin as well as TAT-Cx43CT peptides prevent the inhibition of Cx43-mediated ATP release triggered by
high [Ca2!]i in HeLa cells ectopically expressing Cx43. A) Proposed model for the activation of contractility by high [Ca
2!]i,
provoked by 10 'M A23187. Action of (%)-blebbistatin and TAT-Cx43CT, TAT-Cx43CT)I, and TAT-Cx43CT ! TAT-L2 in this
pathway is indicated. B–D) Quantification of ATP release (fold induction of baseline) in response to different concentrations
of A23187 in Cx43-expressing HeLa cells (n.12). Effect of (%)-blebbistatin and its inactive enantiomer (!)-blebbistatin (B), of
different C-terminal TAT peptides (C), and of TAT-L2 alone or coincubated with TAT-Cx43CT (D). E) Dose-response curve for
the effect of TAT-Cx43 on the suppression of the inhibition of Cx43-hemichannel-mediated ATP release provoked by 10 'M
A23187. F) Dose-response curve for the effect of TAT-L2 on the inhibition of Cx43-hemichannel-mediated ATP release
provoked by 2 'M A23187.
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cells, indicating that Cx43M239 does not form func-
tional hemichannels (Fig. 8A). Furthermore, pre-
treatment of the cells with (%)-blebbistatin was not
able to restore Cx43M239-hemichannel activity. These
data indicate that the CT tail of Cx43 is involved in
sensing the actomyosin contractility, thereby regulat-
ing Cx43-hemichannel activity.
TAT-Cx43CT restores Cx43M239
hemichannel-mediated ATP release
Because Cx43M239 did not display hemichannel responses
on [Ca2!]i increases, we speculated that addition of
TAT-Cx43CT could restore its activity. Strikingly, pretreat-
ment of Cx43M239-expressing HeLa cells with TAT-
Cx43CT restored ATP release on challenging the cells
with 2 'MA23187 (Fig. 8B). Similar results were obtained
with TAT-Cx43CT)I, whereas TAT-Cx43CTrev peptide
did not significantly affected ATP release. The restoration
of ATP release via Cx43M239 hemichannels by TAT-
Cx43CT pretreatment gave a response profile that lacked
the typical bell-shaped [Ca2!]i dependence (i.e., it lacked
the disappearance of the responses at high [Ca2!]i stim-
ulation). This suggests that residues in the CT tail outside
of the region represented by the TAT-Cx43CT peptide
are responsible for sensing the increased contractility.
Moreover, we found that the action of TAT-Cx43CT on
Cx43M239 hemichannels was neutralized by the presence
of TAT-L2. Coincubation of TAT-L2 with TAT-Cx43CT
abolished the TAT-Cx43CT-mediated Cx43M239-
hemichannel activity induced by 2 'M A23187 (Fig. 8C).
This indicates that TAT-L2 acts as a “scaffold” for TAT-
Cx43CT, thereby preventing its stimulatory action on
Cx43M239.
We also checked whether TAT-Cx43CT restored
Cx43M239-hemichannel activity in response to Ca2!-free
solution (Fig. 8D). As previously published (33), Ca2!-
free solution did not provoke ATP release in Cx43M239-
expressing cells, in contrast to cells expressing wild-type
Cx43. However, pretreatment with TAT-Cx43CT re-
stored Cx43M239-hemichannel activity. Again, the effect
of TAT-Cx43CT on Cx43M239 hemichannels was coun-
teracted by coincubation with TAT-L2.
We also determined the dose response for the effect of
TAT-Cx43CT on Cx43M239-hemichannel activity in re-
sponse to 2 'M A23187 (Fig. 8E). These measurements
show that TAT-Cx43CT restored Cx43M239-hemichannel
activity with an EC50 of -30 'M. The highest effect
measured was obtained at 100 'M TAT-Cx43CT.
Furthermore, we also used this system to monitor the
efficiency of uptake of TAT-Cx43CT and TAT-L2 by
measuring Cx43M239-hemichannel activity in response to
2 'M A23187 from cells pretreated with 100 'M of
TAT-Cx43CT and different [TAT-L2] (Fig. 8F). The re-
Figure 8. TAT-Cx43CT peptides are sufficient to restore the activity of Cx43M239 hemichannels and are counteracted by the
presence of TAT-L2. A, B) Quantification of ATP release in response to different concentrations of A23187 in Cx43M239-
expressing HeLa cells (n.12). A) Effect of (%)-blebbistatin. B) Effect of different TAT-Cx43CT peptides. C, D) Effect of
TAT-Cx43CT, TAT-L2, TAT-Cx43CT ! TAT-L2, and TAT-Cx43CTrev ! TAT-L2 on ATP release from Cx43M239-expressing
HeLa cells triggered by 2 'M A23187 (C) or Ca2!-free solution (D). E) Dose-response curve for the effect of TAT-Cx43 on the
restoration of Cx43M239-hemichannel-mediated ATP release provoked by 2 'M A23187. F) Effect of increasing [TAT-L2] on the
TAT-Cx43CT-restored Cx43M239-hemichannel-mediated ATP release in response to 2 'M A23187.
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sults show that 100 'M TAT-L2 is needed to fully block
the effect of 100 'M TAT-Cx43CT, suggesting that TAT-
Cx43CT and TAT-L2 are taken up with similar efficien-
cies, leading to equimolar amounts of both peptides in
the cell and complete scaffolding of TAT-Cx43CT by
TAT-L2.
Finally, we also exploited this system to investigate
whether TAT-Cx43CT can affect Cx50 hemichannels.
Therefore, we used the loop region of Cx50 corre-
sponding to the L2 region of Cx43 as a TAT-fused
peptide (TAT-Cx50L2). Supplemental Fig. 3E shows
that TAT-Cx50L2 is not able to prevent the restoration
of Cx43M239-hemichannel activity by TAT-Cx43CT in
response to 2 'MA23187, suggesting that TAT-Cx43CT
is unlikely to affect Cx50-hemichannel activity.
Taking together all these results, we conclude that
the binding of TAT-Cx43CT to the L2 region of
Cx43M239 is essential for restoring hemichannel activity
in Cx43M239 by TAT-Cx43CT.
TAT-Cx43CT restores Cx43-hemichannel currents in
oocytes
It is known that Cx43 expressed in Xenopus oocytes does
not form functional hemichannels, or at least it is very
hard to detect them in electrophysiological experiments
(59–61). We hypothesized that the lack of Cx43-
hemichannel activity in Xenopus oocytes may be related to
the absence of Cx43-intramolecular interactions. Thus, we
anticipated that TAT-Cx43CT peptides may rescue Cx43-
hemichannel activity in Xenopus oocytes. Therefore,
we measured hemichannel currents in oocytes in-
jected with cRNA of Cx43 and siRNA against Cx38 to
knock down endogenous connexins. Under control
conditions, small currents were observed (0.13+0.11
'A at !60 mV, n.10) (Fig. 9A). However, TAT-
Cx43CT peptide increased the outward Cx43-
hemichannel currents 6.1 times (0.82+0.21 'A at !60
mV, n.9) and provoked a large tail current (Fig. 9B),
whereas TAT-Cx43CTrev did not increase these cur-
rents (0.18+0.13 'A at !60 mV, n.9) and provoked
only a small increase of the tail current (Fig. 9C). I/V
analyses (Fig. 9D) showed that the currents, potentiated
by TAT-Cx43CT, were activated starting from %10 mV
on. The TAT-Cx43CT peptide did not influence the
reversal potential (Fig. 9D), suggesting that TAT-
Cx43CT increases the open probability.
To assess whether the TAT-Cx43CT-induced
hemichannel currents depended on the presence of
Cx43, we performed whole-cell voltage-clamp measure-
ments on oocytes that were only injected with siRNA
against Cx38 (Fig. 9E, F). Hence, in oocytes lacking
ectopic Cx43 expression, no hemichannel-mediated cur-
rents were observed (Fig. 9E). Furthermore, TAT-Cx43CT
did not provoke any additional hemichannel currents (Fig.
9F). Quantitative analysis of the whole-cell voltage-clamp
measurements performed on siCx38-treated oocytes re-
vealed that the currents obtained from theuntreated oocytes
Figure 9. TAT-Cx43CT peptides restore Cx43 hemichannel-mediated currents in Cx43-overexpressing oocytes. A–C) Ttypical
whole-cell currents as a function of time in response to 10 mV voltage steps in Cx43-expressing oocytes (gray). Currents obtained
at 0 mV are indicated in black. Endogenous Cx38 was knocked down by siRNA. Currents were measured in untreated (A),
TAT-Cx43CT-treated (B), and TAT-Cx43CTrev-treated (C) Cx43-expressing oocytes. D) I/V plot for Cx43-expressing oocytes
untreated or treated with either TAT-Cx43CT or TAT-CX43CTrev. E, F) Typical whole-cell currents as a function of time in
response to different voltage steps in oocytes only injected with Cx38 siRNA. Currents were measured in untreated (E) and
TAT-Cx43CT-treated (F) oocytes.
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did not significantly differ from the currents obtained from
the TAT-Cx43CT-treated oocytes (0.09+0.04 and 0.12+0.11
'A, respectively). This indicates that the TAT-Cx43CT-
induced hemichannel currents observed in Cx43-expressing
oocytes are mediated through Cx43.
DISCUSSION
There are 2 major findings in the present study: intramo-
lecular loop/tail interactions are critical for Cx43-
hemichannel activity, and activation of the actomyosin
contractile system inhibits Cx43 hemichannels by interfer-
ing with these intramolecular loop/tail interactions.
Different observations support this hypothesis: TAT-
Cx43CT overcame thrombin-induced inhibition of Cx43-
hemichannel opening, whereas TAT-L2 caused inhibition
of Cx43-hemichannel opening; the inhibitory action of
TAT-L2 was abolished by 2 mutations (H126K/I130N)
shown to be important for loop/tail interaction; TAT-
Cx43CT was sufficient to restore [Ca2!]i-induced open-
ing of nonfunctional Cx43M239 hemichannels; biotin-
Cx43CT was sufficient to bind the L2 region of Cx43 in
SPR experiments; and the inhibitory action of TAT-L2 on
Cx43-hemichannel responses was neutralized by coincu-
bation with TAT-Cx43CT and vice versa. We therefore
propose a novel model for the regulation of Cx43-
hemichannel activity by intramolecular protein interac-
tion between the CT tail and the CL, providing novel
insights in the cell biological regulation of Cx43
hemichannels (Fig. 10).
Intercellular communication in primary BCECs is
mainly mediated via Cx43 hemichannels
Although Cx43 forms functional GJs that participate in
intercellular propagation of Ca2! waves in BCECs,
previous experiments (28) and new experiments in the
current paper demonstrate that intercellular Ca2!-wave
propagation in BCECs mainly depends on ATP release
via Cx43 hemichannels. Hydrolysis of ATP by applica-
tion of apyrase resulted in a marked reduction of the
Ca2!-wave propagation. In these conditions, applica-
tion of Cx43 siRNA had no significant effect on Ca2!-
wave propagation. On the other hand, application of
the ecto-nucleotidase inhibitor ARL-67156 resulted in a
very large increase in active area, which was more than
10-fold higher than the active area under conditions
when ATP-dependent Ca2!-wave propagation was in-
hibited by apyrase. Cx43 siRNA reduced that active area
in the presence of ARL-67156 by more than 50%. These
results exclude the possibility that a major part of the
Cx43 siRNA-inhibition of functional responses is due to
reduction of GJ communication.
Although our experiments demonstrated the contri-
bution of Cx43-mediated ATP release to intercellular
Ca2!-wave propagation in BCECs, our results also indi-
cate that Cx43 hemichannels may not be the only
pathway responsible for ATP release from these cells,
because a nearly complete knockdown of Cx43 reduces
the active area of the Ca2! wave or the amount of ATP
released from these cells by only -60%. This indicates
that other connexin and pannexin hemichannels may
be present and contribute to ATP release in these cells.
One such candidate is Cx50, which is highly expressed
in the lens of the eye (62). However, although we found
Cx50 mRNA in BCECs (52), we could not detect the
Cx50 protein in BCEC protein by Western blot analysis.
This result confirms an earlier study, reporting that the
Cx50 protein could not be detected in the rat corneal
endothelial cells, while the Cx50 mRNA was present
(63). This suggests that Cx50 is either not present in
these cells or present only at very low amounts. Never-
theless, we excluded the contribution of Cx50 in our
system by using TAT-Cx50CT and TAT-Cx50L2 pep-
tides, which did not have any effect on Ca2!-wave
propagation or on the inhibition of Ca2!-wave propa-
gation by thrombin in these cells. However, Cx26,
Cx30.3, Cx32, Cx36, Cx45, Cx46, and Cx46.6 and
Panx1, Panx2, and Panx3 could possibly contribute to
the Ca2!-wave propagation, because we detected the
mRNA of these connexin and pannexin isoforms in
BCECs (52). Further studies are needed to document
their contribution in the hemichannel-mediated ATP
release in BCECs. Preliminary results indicate that
pannexins might not be likely to contribute to ATP-
dependent intercellular communication upon mechan-
ical stimulation of these cells, because low concentra-
tions of carbenoxolone (5 'M) reported to inhibit
pannexins but not connexin hemichannels at these
concentrations (5, 64) did not affect the active area of
the Ca2! wave in these cells (unpublished results).
Opening and closing of Cx43 hemichannel during
physiological Ca2! signaling
Although several reports document the opening of
Cx43 hemichannels during pathophysiological condi-
tions, such as cerebral and cardiac ischemic insults, it
remained an open question whether Cx43 hemichan-
nels open during physiological signaling. Therefore,
this study together with previous reports indicates that
Cx43 hemichannels can be activated by rises in [Ca2!]i
in the physiological range. Increasing [Ca2!]i from its
resting value of -100 to -300 nM induces a significant
opening of Cx43 hemichannels, as measured by ATP-
release experiments. Furthermore, similar findings
were obtained for Cx32 (34), indicating that physiolog-
ical Ca2! signaling may affect the activity of several
types of connexin hemichannels.
Therefore, it is likely that not only pannexin
hemichannels, but also Cx43 (and Cx32) hemichannels
can open during physiological intracellular Ca2! signal-
ing, a universal signaling pathway that can be activated
in response to growth factors, hormones, signaling
molecules (such as ATP), and antibodies that bind to
phospholipase C#/$-coupled receptors, resulting in
opening of inositol 1,4,5-tris phosphate receptors.
Although the opening of Cx43 and Cx32 hemichan-
nels during agonist-induced and mechanical stress-
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induced Ca2! signaling needs to be explored further,
the findings imply that connexin-made hemichannels
not only open during pathophysiological conditions,
but also may also open during physiological signaling,
and that both pannexin-made and connexin-made
hemichannels can open during physiological signaling,
both contributing to the physiological coordination of
processes in a variety of tissues and organs.
In this work, we identified a brake mechanism that
prevents the opening of Cx43 hemichannels during
Ca2! signaling. It was already known before that throm-
bin or high [Ca2!]i increases inhibits Cx43-hemichan-
nel activity (56). We identified activation of the acto-
myosin contractile system as the mechanism that is
responsible for the thrombin-induced inhibition of
Cx43-hemichannel activity. This could act as a protec-
tive mechanism that prevents excessive opening of
Cx43 hemichannels at high [Ca2!]i. It remains to be
elucidated whether other connexin or pannexin
hemichannels are inhibited by the contractile system.
In particular, the opening of Cx32 hemichannels may
be prevented by the activation of the contractile system
in response to high [Ca2!]i.
Intramolecular loop/tail interactions are required for
Cx43 hemichannel activity and are influenced by the
contractile system
We propose that functional Cx43 hemichannels display
an intramolecular loop/tail interaction, which is essen-
tial for their activity (Fig. 10). Under conditions of mild
activation (MS or moderate [Ca2!]i elevation), the
actomyosin contractility is not sufficiently increased,
and the loop/tail association is not disturbed. Addition
of either (%)-blebbistatin or TAT-Cx43CT under these
conditions will not affect the activity. However, under
conditions of strong activation (either by the presence
of thrombin known to sensitize the contractile system
to Ca2! or by strong [Ca2!]i elevation), a strong
actomyosin contraction may occur, leading to a phys-
ical dislodgement of the tail from the loop and
closure of the channel. Blocking actomyosin contrac-
tility by inhibiting the myosin II-ATPase activity pre-
vents the physical dislodgement of the tail from the
loop, thereby keeping the Cx43 hemichannels open.
Finally, we hypothesize that TAT-Cx43CT binds to
the L2 region, thereby competing for the endoge-
nous loop/tail interaction, rendering Cx43-
Figure 10. Model for the regulation of Cx43
and Cx43M239-hemichannel activity by contrac-
tility, TAT-Cx43CT and TAT-L2. Left panel:
Cx43 hemichannels. We anticipate that func-
tional Cx43 hemichannels possess an intramo-
lecular loop/tail interaction, which is essential
for their activity and which is regulated by
contractility. Functional opening and closure of
Cx43 hemichannels in response to stimuli
(given at top) and different drug/peptide treat-
ments (given at left) are depicted in green and
red, respectively. The X protein resembles the
actomyosin contractile system. Activation of the
actomyosin contractile system is indicated by a
red X, whereas conditions in which the acto-
myosin contractile system is not activated or
inhibited (e.g., by (%)-blebbistatin) are indi-
cated by a green X. However, at this moment, it
is not known whether the actomyosin directly
associates with Cx43 hemichannels or via a
linker protein. See text for further explanation
of the model. Right panel: Cx43M239 hemichan-
nels. Addition of (%)-blebbistatin does not re-
store Cx43M239-hemichannel activity, indicating
that the regulation of Cx43-hemichannel activity
by contractility requires the presence of the C-
terminal tail. Addition of TAT-Cx43CT or TAT-
Cx43CT)I restores Cx43M239-hemichannel activ-
ity. Because Cx43CT is able to associate with the
intracellular L2 region of Cx43 and the action of
TAT-Cx43CT on Cx43M239 is neutralized by the
presence of TAT-L2, we hypothesize that TAT-
Cx43CT restores Cx43M239-hemichannel activity
by binding to the L2 region. This indicates that a
functional Cx43M239 hemichannel requires the
intramolecular loop/tail interaction.
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hemichannel activity independent of the endoge-
nous loop/tail interaction and insensitive to
enhanced actomyosin contractility. In contrast, treat-
ing the cells with TAT-L2 will cause inhibition of
Cx43-hemichannel responses, likely by binding to the
last 10 aa of the CT tail, thereby disrupting the
intramolecular interaction between the CT tail and
the endogenous L2 region. Finally, coincubation of
TAT-Cx43CT and TAT-L2 will reciprocally neutralize
each other’s actions on hemichannels, since they act as
a scaffold for each other. As a result, neither TAT-Cx43CT
nor TAT-L2 will be able to interfere with the endogenous
loop/tail interactions, and Cx43 hemichannels will dis-
play their normal phenotypic responses. Based on this
model, it is tempting to speculate that our data point to a
tethering model (65) for the gating of Cx43 hemichan-
nels, suggesting that contractility acting via cytoskeletal
tethers and loop/tail interactions have a major modulat-
ing influence on Cx43-hemichannel gating. Actomyosin
contraction would dislodge the CT tail from the loop and
thereby close the channel. However, in addition to con-
tractility, direct effects of Ca2! on the conformation of the
CT and interaction with the intracellular loop of Cx43
have been reported (66) but do not seem sufficient to
explain our results, because (%)-blebbistatin could over-
come Cx43-hemichannel closure provoked by high
[Ca2!]i. Furthermore, in this model, we cannot exclude
that TAT-Cx43CT peptides may interfere with Ca2!-
dependent refolding of the endogenous CT of Cx43 (66).
However, the fact that TAT-Cx43CT also restored the
activity of Cx43M239 hemichannels that lack the complete
CT seems to indicate that effects of TAT-Cx43CT on CT
are not involved.
The link between actomyosin cytoskeleton and Cx43
hemichannels can occur either directly or through a yet
unidentified linker protein (protein X in Fig. 10).
However, how the CT of Cx43 senses actomyosin con-
tractility remains to be elucidated. At least for Cx43 GJ
channels, many proteins of the cytoskeleton or associ-
ated with the cytoskeleton have been proposed to
interact with Cx43, including ZO-1 (48), drebrin (67),
Src (50), CIP85 (68), CCN3 (69–71), and cortactin
(72). To date, it is not known whether these candidate
proteins also interact with Cx43 hemichannels. Never-
theless, we may exclude ZO-1 as a likely candidate,
because the effects of TAT-Cx43CT were independent
of the last isoleucine residue essential for binding ZO-1,
and because Cx43 hemichannels did not coimmuno-
precipitate with ZO-1.
Lack of activity of Cx43M239 hemichannels is due to
the absence of loop/tail interactions
Cx43M239, which lacks its CT tail, does not form func-
tional hemichannels at the plasma membrane (Fig. 10).
Addition of (%)-blebbistatin does not restore Cx43M239-
hemichannel activity, indicating that the regulation of
Cx43-hemichannel activity by contractility requires its
CT tail. Addition of TAT-Cx43CT or TAT-Cx43CT)I
restores Cx43M239-hemichannel activity. Since
Cx43CT is able to associate with the intracellular L2
region of Cx43, we hypothesize that TAT-Cx43CT
restores Cx43M239-hemichannel activity by binding to
the L2 region. This hypothesis is supported by the
fact that the action of TAT-Cx43CT on Cx43M239-
hemichannel activity is abolished in the presence of
TAT-L2. This indicates that functional Cx43M239
hemichannels require the loop/tail interaction and that
the last 10 aa of the tail are sufficient to provoke Cx43M239-
hemichannel opening in response to hemichannel activa-
tors. It is important to note that the association of TAT-
Cx43CT with the CL per se is not sufficient to cause Cx43
or Cx43M239-hemichannel opening by itself, but still re-
quires a trigger, such as MS, Ca2!-free solution, or mod-
erate [Ca2!]i elevations.
$-Helical properties of the loop region are important
for interaction with the CT of Cx43
Our data suggest that the higher-order conformation of
the L2 region is essential for its function as an acceptor for
the CT Cx43 residues, because the TAT-L2H126K/I130N, a
peptide variant that has lost its "-helical properties and its
binding activity to the complete CT tail of Cx43, was not
able to inhibit Cx43 hemichannel responses, and the
binding of TAT-L2 to immobilized biotin-Cx43CT was
enhanced by lowering the pH, which is known to favor the
"-helical structure of the L2 region (21). This pH-
dependent regulation of loop/tail interaction has been
proposed to be responsible for closure of Cx43 GJ chan-
nels (73) and may therefore also be relevant for the
increased opening of C43 hemichannels in the context of
brain and heart ischemia, in which a decrease in intracel-
lular pH has been observed (74, 75).
Loop/tail interactions differentially regulate Cx43
GJs and hemichannels
An important finding emerging from this study is that
Cx43-hemichannel responses and GJ coupling are dif-
ferentially regulated by intramolecular loop/tail inter-
actions. Indeed, it has been shown before that binding
of the CT tail (ball) to the CL (receptor) causes
inhibition of Cx43 GJs (17–19, 22), whereas in our
experiments the binding of the CT tail to the CL comes
up as an essential step for rendering Cx43 hemichan-
nels in an activable state. Our data therefore indicate
that this intramolecular loop/tail interaction will facil-
itate the opening of Cx43 hemichannels in response to
known hemichannel stimuli, such as MS, Ca2!-free
solution, moderate [Ca2!]i increase, and membrane
depolarization. In agreement with our findings, several
reports have indicated that GJs and hemichannels are
regulated in opposite ways (9, 76). Under inflammatory
conditions, cytokines released by microglia have an
opposite effect on GJ communication and hemichan-
nel communication in astrocytes (13). Increased intra-
cellular oxidative stress leads to a decreased Cx43-
mediated GJ communication but to augmented Cx43-
hemichannel activity (12, 77). Cortical astrocytes
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subjected to metabolic inhibition display a decreased
Cx43-mediated GJ coupling with an increased Cx43-
hemichannel opening (14). In Cx43-expressing C6 gli-
oma cells, lipopolysaccharide, and basic fibroblast growth
factor inhibit GJ coupling, whereas they stimulate
hemichannel-mediated ATP release (33). CT tagging of
Cx43 with GFP increases the GJ plaque size, enhancing GJ
communication (78, 79), whereas it hampers the Cx43
hemichannel-mediated ATP release (58). Cx43 proteins
lacking their CT tail were not able to form functional
hemichannels (33, 58), whereas they are able to form
functional GJ channels (33, 80). Mutations in Cx43
(G138R and G143S) that are linked with oculodentodigi-
tal dysplasia (ODDD) disrupt GJ coupling, but display
increased ATP-releasing hemichannel activity (81). This
opposite regulation of hemichannels and GJs may be a
cellular strategy to switch between cell-death and cell-
protective strategies in cells experiencing severe patholog-
ical stimuli, such as ischemic insults or proinflammatory
cytokines, or in cells undergoing prosurvival signaling,
such as during exposure to lipopolysaccharide and basic
fibroblast growth factor.
Physiological and therapeutical importance of
loop/tail interactions for Cx43-hemichannel activity
Our findings provide novel insights into the mecha-
nism by which Cx43-hemichannel activity is regulated.
In physiological perspective, the inhibition of Cx43-
hemichannel activity by increased contractility may act
as a brake on massive Cx43-hemichannel opening,
thereby preventing high membrane permeability and
the collapse of ionic and metabolic gradients that
would be lethal for cells (7, 8). Understanding the
exact molecular mechanism by which intramolecular
loop/tail interactions affect Cx43-hemichannel activity
is of fundamental importance to enable rational drug
design of small therapeutic molecules that prevent
excessive opening of Cx43-hemichannels under patho-
logical conditions. Because excessive Cx43-hemichan-
nel opening during brain or cardiac ischemic insults or
inflammation contributes to the collapse of metabolic
and energy gradients as well as to the spreading of
cell-death factors, the application of small molecules
that prevent this opening by interfering with the loop/
tail interactions may be of clinical relevance as a novel
therapeutic strategy to reduce or prevent tissue dam-
age. In particular, the importance of the loop region
for the control of Cx43-hemichannel activity is high-
lighted by the fact that ODDD-associated mutations
in the L2 region of Cx43 lead to either inhibition
(e.g., I130T) or stimulation (e.g., G138R, G143S) of
Cx43-hemichannel activity (81–84). Therefore, it
would be intriguing to investigate whether these
mutations affect the binding of L2 to CT and whether
changes in loop/tail interactions can account for the
altered Cx43-hemichannel activity observed with
these ODDD mutations.
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